top of page
Search


FDA's GenAI Medical Device Paper Is a Starting Gun, Not a Warning Shot
The FDA just issued a discussion paper on regulating Generative AI as a medical device. Most healthcare executives will file it under "watch and wait." That is the wrong read. I have spent my career inside federal health IT, at NCQA, and now advising healthcare organizations through some of the most demanding compliance frameworks in the industry. I know exactly what happens between a federal discussion paper and an enforcement action. The gap is shorter than you think. The R

Rick Moore
Sep 145 min read
Â
Â
Â


When the Ransomware Writes Itself: What Autonomous AI Attacks Mean for Healthcare Governance
Sysdig researchers documented what they believe is the first fully autonomous, AI-agent-driven ransomware attack: the agent exploited an unpatched Langflow flaw (CVE-2025-3248), stole credentials, moved laterally and encrypted data without human direction. This is not an academic thought experiment. It is an operational preview of the threat environment your security team will face, possibly before your organization's next board meeting. Healthcare executives need to hear thi

Rick Moore
Jul 65 min read
Â
Â
Â


When Your AI Vendor Becomes Your Breach Vendor: The Xsolis Incident and What It Demands From Healthcare Leaders
The Xsolis breach is not another footnote in the HHS OCR breach portal. It is a signal that the threat model for healthcare organizations has fundamentally shifted, and most vendor risk programs have not kept up. When a single AI-powered business associate holds clinical and utilization data across multiple covered entities, a successful attack on that vendor is not a vendor problem. It is a system-wide PHI event affecting 1.4 million individuals across an unknown number of h

Rick Moore
Jun 295 min read
Â
Â
Â
bottom of page